Going PRO: FDA Suggests Best Practices For Choosing, Changing Patient-Reported Outcome Tools
Executive Summary
Patient-Reported Outcome (PRO) instruments are the focus of a 26 January final guidance from the US agency. Sponsors can lean on the guidance when selecting, developing or modifying tools for patient data collection.